Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging

Abstract Along with the decline in oocyte quality, numerous defects such as mitochondrial insufficiency and the increase of mutation and deletion have been reported in oocyte mitochondrial DNA (mtDNA) following aging. Any impairments in oocyte mitochondrial function have negative effects on the repr...

Full description

Bibliographic Details
Main Authors: Halimeh Mobarak, Mohammad Heidarpour, Pei-Shiue Jason Tsai, Aysa Rezabakhsh, Reza Rahbarghazi, Mohammad Nouri, Mahdi Mahdipour
Format: Article
Language:English
Published: BMC 2019-11-01
Series:Cell & Bioscience
Subjects:
Online Access:https://doi.org/10.1186/s13578-019-0360-5
id doaj-139ca914f0d8451eaf7db7d1689bbfd8
record_format Article
spelling doaj-139ca914f0d8451eaf7db7d1689bbfd82020-11-29T12:20:55ZengBMCCell & Bioscience2045-37012019-11-019111510.1186/s13578-019-0360-5Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during agingHalimeh Mobarak0Mohammad Heidarpour1Pei-Shiue Jason Tsai2Aysa Rezabakhsh3Reza Rahbarghazi4Mohammad Nouri5Mahdi Mahdipour6Women’s Reproductive Health Research Center, Tabriz University of Medical SciencesDepartment of Clinical Sciences, Faculty of Veterinary Medicine, Ferdowsi University of MashhadCenter for Developmental Biology and Regenerative Medicine Research, National Taiwan University/NTUAging Research Institute, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesStem Cell Research Center, Tabriz University of Medical SciencesAbstract Along with the decline in oocyte quality, numerous defects such as mitochondrial insufficiency and the increase of mutation and deletion have been reported in oocyte mitochondrial DNA (mtDNA) following aging. Any impairments in oocyte mitochondrial function have negative effects on the reproduction and pregnancy outcome. It has been stated that infertility problems caused by poor quality oocytes in women with in vitro fertilization (IVF) and repeated pregnancy failures are associated with aging and could be overcome by transferring large amounts of healthy mitochondria. Hence, researches on biology, disease, and the therapeutic use of mitochondria continue to introduce some clinical approaches such as autologous mitochondrial transfer techniques. Following mitochondrial transfer, the amount of ATP required for aged-oocyte during fertilization, blastocyst formation, and subsequent embryonic development could be an alternative modality. These modulations improve the pregnancy outcome in women of high reproductive aging as well. In addition to overview the clinical studies using mitochondrial microinjection, this study provides a framework for future approaches to develop effective treatments and preventions of congenital transmission of mitochondrial DNA mutations/diseases to offspring. Mitochondrial transfer from ovarian cells and healthy oocytes could lead to improved fertility outcome in low-quality oocytes. The modulation of mitochondrial bioactivity seems to regulate basal metabolism inside target oocytes and thereby potentiate physiological activity of these cells while overcoming age-related infertility in female germ cells.https://doi.org/10.1186/s13578-019-0360-5Oocyte qualityMitochondrial transferAgeingReproduction
collection DOAJ
language English
format Article
sources DOAJ
author Halimeh Mobarak
Mohammad Heidarpour
Pei-Shiue Jason Tsai
Aysa Rezabakhsh
Reza Rahbarghazi
Mohammad Nouri
Mahdi Mahdipour
spellingShingle Halimeh Mobarak
Mohammad Heidarpour
Pei-Shiue Jason Tsai
Aysa Rezabakhsh
Reza Rahbarghazi
Mohammad Nouri
Mahdi Mahdipour
Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
Cell & Bioscience
Oocyte quality
Mitochondrial transfer
Ageing
Reproduction
author_facet Halimeh Mobarak
Mohammad Heidarpour
Pei-Shiue Jason Tsai
Aysa Rezabakhsh
Reza Rahbarghazi
Mohammad Nouri
Mahdi Mahdipour
author_sort Halimeh Mobarak
title Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
title_short Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
title_full Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
title_fullStr Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
title_full_unstemmed Autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
title_sort autologous mitochondrial microinjection; a strategy to improve the oocyte quality and subsequent reproductive outcome during aging
publisher BMC
series Cell & Bioscience
issn 2045-3701
publishDate 2019-11-01
description Abstract Along with the decline in oocyte quality, numerous defects such as mitochondrial insufficiency and the increase of mutation and deletion have been reported in oocyte mitochondrial DNA (mtDNA) following aging. Any impairments in oocyte mitochondrial function have negative effects on the reproduction and pregnancy outcome. It has been stated that infertility problems caused by poor quality oocytes in women with in vitro fertilization (IVF) and repeated pregnancy failures are associated with aging and could be overcome by transferring large amounts of healthy mitochondria. Hence, researches on biology, disease, and the therapeutic use of mitochondria continue to introduce some clinical approaches such as autologous mitochondrial transfer techniques. Following mitochondrial transfer, the amount of ATP required for aged-oocyte during fertilization, blastocyst formation, and subsequent embryonic development could be an alternative modality. These modulations improve the pregnancy outcome in women of high reproductive aging as well. In addition to overview the clinical studies using mitochondrial microinjection, this study provides a framework for future approaches to develop effective treatments and preventions of congenital transmission of mitochondrial DNA mutations/diseases to offspring. Mitochondrial transfer from ovarian cells and healthy oocytes could lead to improved fertility outcome in low-quality oocytes. The modulation of mitochondrial bioactivity seems to regulate basal metabolism inside target oocytes and thereby potentiate physiological activity of these cells while overcoming age-related infertility in female germ cells.
topic Oocyte quality
Mitochondrial transfer
Ageing
Reproduction
url https://doi.org/10.1186/s13578-019-0360-5
work_keys_str_mv AT halimehmobarak autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
AT mohammadheidarpour autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
AT peishiuejasontsai autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
AT aysarezabakhsh autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
AT rezarahbarghazi autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
AT mohammadnouri autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
AT mahdimahdipour autologousmitochondrialmicroinjectionastrategytoimprovetheoocytequalityandsubsequentreproductiveoutcomeduringaging
_version_ 1724411967879249920